Login / Signup

Complications and Outcomes in 39,864 Patients Receiving Standard Care Plus Mechanical Circulatory Support or Standard Care Alone for Infarct-Associated Cardiogenic Shock.

Jan-Sören PadbergJannik FeldLeonie PadbergJeanette KöppeLena MakowskiJoachim GerßPatrik DrögeThomas RuhnkeChristian GünsterStefan Andreas LangeHolger Reinecke
Published in: Journal of clinical medicine (2024)
Our data show noticeably more in-hospital complications in patients on tMCS and higher mortality with V-A ECMO and Impella. The use of both devices is an independent risk factor for mortality, whereas the use of IABP is associated with a survival benefit.
Keyphrases